Weng, Yihe https://orcid.org/0009-0005-2628-9492
Boyle, Rory
Lee, Chi Tak
Quinn, Declan
Earley, Clodagh
Splittgerber, Maike
Zhang, Lili
Franzen, Luisa
Banaschewski, Tobias https://orcid.org/0000-0003-4595-1144
Bokde, Arun L. W. https://orcid.org/0000-0003-0114-4914
Desrivières, Sylvane https://orcid.org/0000-0002-9120-7060
Flor, Herta https://orcid.org/0000-0003-4809-5398
Grigis, Antoine
Garavan, Hugh https://orcid.org/0000-0002-8939-1014
Gowland, Penny https://orcid.org/0000-0002-4900-4817
Heinz, Andreas
Brühl, Rüdiger https://orcid.org/0000-0003-0111-5996
Martinot, Jean-Luc https://orcid.org/0000-0002-0136-0388
Martinot, Marie-Laure Paillère
Artiges, Eric https://orcid.org/0000-0003-4461-7646
McGrath, Jane
Nees, Frauke https://orcid.org/0000-0002-7796-8234
Papadopoulos Orfanos, Dimitri https://orcid.org/0000-0002-1242-8990
Poustka, Luise
Holz, Nathalie https://orcid.org/0000-0002-6225-9267
Hohmann, Sarah
Smolka, Michael N. https://orcid.org/0000-0001-5398-5569
Vaidya, Nilakshi
Schumann, Gunter https://orcid.org/0000-0002-7740-6469
Walter, Henrik https://orcid.org/0000-0002-9403-6121
Weigard, Alexander https://orcid.org/0000-0003-3820-6461
Whelan, Robert https://orcid.org/0000-0002-2790-7281
,
Nees, Frauke
Holz, Nathalie
Hohmann, Sarah
Article History
Received: 22 November 2025
Revised: 28 February 2026
Accepted: 23 March 2026
First Online: 22 April 2026
Competing interests
: Dr Banaschewski served in an advisory or consultancy role for eye level, Infectopharm, Medice, Neurim Pharmaceuticals, Oberberg GmbH and Takeda. He received conference support or speaker’s fee by Janssen-Cilag, Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Dr Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fee by Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.